» Articles » PMID: 36363758

SARS-CoV-2 As a Zooanthroponotic Infection: Spillbacks, Secondary Spillovers, and Their Importance

Overview
Journal Microorganisms
Specialty Microbiology
Date 2022 Nov 11
PMID 36363758
Authors
Affiliations
Soon will be listed here.
Abstract

In the midst of a persistent pandemic of a probable zoonotic origin, one needs to constantly evaluate the interplay of SARS-CoV-2 (severe acute respiratory syndrome-related coronavirus-2) with animal populations. Animals can get infected from humans, and certain species, including mink and white-tailed deer, exhibit considerable animal-to-animal transmission resulting in potential endemicity, mutation pressure, and possible secondary spillover to humans. We attempt a comprehensive review of the available data on animal species infected by SARS-CoV-2, as presented in the scientific literature and official reports of relevant organizations. We further evaluate the lessons humans should learn from mink outbreaks, white-tailed deer endemicity, zoo outbreaks, the threat for certain species conservation, the possible implication of rodents in the evolution of novel variants such as Omicron, and the potential role of pets as animal reservoirs of the virus. Finally, we outline the need for a broader approach to the pandemic and epidemics, in general, incorporating the principles of One Health and Planetary Health.

Citing Articles

Improving the ONE HEALTH approach: a lesson from SARS-CoV-2 pandemic.

Marchi S, Guarducci G, Marotta M, Peccetti B, Viviani S, Messina G J Prev Med Hyg. 2025; 65(3):E312-E322.

PMID: 39758773 PMC: 11698111. DOI: 10.15167/2421-4248/jpmh2024.65.3.3187.


SARS-CoV-2 infection and transmission via the skin to oro-nasal route with the production of bioaerosols in the ferret model.

Shipley R, Seekings A, Byrne A, Shukla S, James J, Goharriz H J Gen Virol. 2024; 105(9).

PMID: 39292223 PMC: 11410047. DOI: 10.1099/jgv.0.002022.


Time-Dependent Effects of Clinical Interventions on SARS-CoV-2 Immunity in Patients with Lung Cancer.

Mack P, Hsu C, Rodilla A, Gomez J, Cagan J, Huang Y Vaccines (Basel). 2024; 12(7).

PMID: 39066351 PMC: 11281667. DOI: 10.3390/vaccines12070713.


High prevalence of SARS-CoV-2 antibodies and low prevalence of SARS-CoV-2 RNA in cats recently exposed to human cases.

Daigle L, Khalid H, Gagnon C, Arsenault J, Bienzle D, Bisson S BMC Vet Res. 2024; 20(1):304.

PMID: 38982461 PMC: 11232172. DOI: 10.1186/s12917-024-04150-4.


Breaking the Barrier: SARS-CoV-2 Infections in Wild and Companion Animals and Their Implications for Public Health.

Abay Z, Sadikaliyeva S, Nurpeisova A, Jekebekov K, Shorayeva K, Yespembetov B Viruses. 2024; 16(6).

PMID: 38932248 PMC: 11209598. DOI: 10.3390/v16060956.


References
1.
Edwards S, Chatterjee H, Santini J . Anthroponosis and risk management: a time for ethical vaccination of wildlife?. Lancet Microbe. 2021; 2(6):e230-e231. PMC: 8016401. DOI: 10.1016/S2666-5247(21)00081-1. View

2.
Fernandez-Bellon H, Rodon J, Fernandez-Bastit L, Almagro V, Padilla-Sole P, Lorca-Oro C . Monitoring Natural SARS-CoV-2 Infection in Lions () at the Barcelona Zoo: Viral Dynamics and Host Responses. Viruses. 2021; 13(9). PMC: 8472846. DOI: 10.3390/v13091683. View

3.
Mishra A, Kumar N, Bhatia S, Aasdev A, Kanniappan S, Sekhar A . SARS-CoV-2 Delta Variant among Asiatic Lions, India. Emerg Infect Dis. 2021; 27(10):2723-2725. PMC: 8462327. DOI: 10.3201/eid2710.211500. View

4.
Anthony S, Epstein J, A Murray K, Navarrete-Macias I, Zambrana-Torrelio C, Solovyov A . A strategy to estimate unknown viral diversity in mammals. mBio. 2013; 4(5):e00598-13. PMC: 3760253. DOI: 10.1128/mBio.00598-13. View

5.
Garigliany M, Van Laere A, Clercx C, Giet D, Escriou N, Huon C . SARS-CoV-2 Natural Transmission from Human to Cat, Belgium, March 2020. Emerg Infect Dis. 2020; 26(12):3069-3071. PMC: 7706966. DOI: 10.3201/eid2612.202223. View